Business
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer.
About this update from Avenir Wellness Solutions Inc.
[{"type":"text","content":"\nOXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s Chief Financial Officer. Bringing his expertise in venture capital, Katz will oversee the company’s financial functions and investment relations.\n “Our company is approaching 2019 amidst exponential growth and a clear vision to be a leader in drug delivery innovation,” said Robert Davidson, CEO and Chairman of the Board of CURE Pharmaceutical. “Alex brings a deep breadth of financial leadership to our growing operations and will be a key addition to our management team.” For 30 years, Katz has worked with seed, early-stage and growth companies in diverse leadership capacities. Recently, he served as a managing partner for ff Venture Capital and Differential Venture Partners, where he handled business management areas including investor relations, human resources and financial planning. As a director at Eventus Advisory Group, he worked with companies, including CURE Pharmaceutical, to establish and achieve financial goals and adhere to corporate governance and regulatory obligations. “It’s prime time to be joining CURE, a forward-thinking corporation that’s revolutionizing drug delivery,” said Katz. “I’m committed to boosting the company’s financial profile and aligning CURE with top-tier investors and shareholders.”   Katz has a Bachelor of Science in accounting from Drexel University and a Juris Doctor degree from the Temple University Beasley School of Law. About CURE Pharmaceutical CURE Pharmaceutical is a fully integrated drug delivery and development committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has an industry leading full-service cGMP manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), the most advanced oral thin film on the market today. CURE has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical ca...